Cite

HARVARD Citation

    Kuster, S. et al. (2022). Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD open. 8 (2), p. . [Online]. 
  
Back to record